# Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

> **NCT00353431** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 130 (actual)

## Conditions studied

- Hyperglycemias

## Interventions

- **DRUG:** Novorapid ®, Novo Nordisk, Denmark

## Key facts

- **NCT ID:** NCT00353431
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-10
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2012-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353431, "Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00353431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*